CAS NO:1138245-21-2 Mirogabalin besylate
CAS NO:1138245-21-2 NAME:Mirogabalin besylate MF:C18H25NO5S MW:367.46 Purity:98% Appearance:white powder COA:Provide Sample:Negotiable
Categories:
Life Science Chemicals
Pharmaceutical Intermediates
Email:sale06@alfachem.cn
Product introduction
| PRODUCT NAME | Mirogabalin besylate |
| CAS NO | 1138245-21-2 |
| Other name | 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid besylate |
| STORAGE | 2-8°C |
| DELIVERY | 2-3DAYS |
| PACKAGE | According client's request |
Description of CAS NO:1138245-21-2 Mirogabalin besylate
Mirogabalin besylate CAS NO:1138245-21-2 is a drug that is used to treat neuropathic pain, postherpetic neuralgia, and other disorders. Mirogabalin besylate is an analog of gabapentin with increased solubility in water and a decreased solubility in organic solvents. Mirogabalin besylate has been shown to be safe and have a good efficacy profile in clinical development. It has also been shown to be effective in the treatment of depression.
Mirogabalin besylate (DS-5565)CAS NO:1138245-21-2 is a novel potent, selective ligand of the α2δ subunit of voltage-gated calcium channels . It is a member of the gabapentinoid drug class, which includes gabapentin and pregabalin . Mirogabalin was developed by Daiichi Sankyo and was first approved in Japan for the treatment of peripheral neuropathic pain (PNP), including diabetic PNP and postherpetic neuralgia .

Applications of CAS NO:1138245-21-2 Mirogabalin besylate
1.Treatment of Peripheral Neuropathic Pain
2.Analgesic Effects in Fibromyalgia Models
3.Treatment of Postherpetic Neuralgia
4.Anxiolytic Effects in Neuropathic Pain Model
Future Directions:
Mirogabalin besylate shows promise as a novel, safe gabapentinoid anticonvulsant with a greater therapeutic effect for neuropathic pain in the dorsal root ganglion and lower adverse drug reactions in the cerebellum . Further studies are needed to explore the role of mirogabalin in cancer pain, postoperative pain, and neuropathic pain due to various other etiologies .
Key words:
Related Products
Related Products
Inquiry